Ironwood Pharmaceuticals IRWD Total Liabilities & Equity
Total Liabilities & Equity at other companies
Other financials
Where this comes from
Reported directly by Ironwood Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesAndStockholdersEquity.
The official record: Ironwood Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ironwood Pharmaceuticals's total liabilities & equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ironwood Pharmaceuticals's total liabilities & equity?
- Ironwood Pharmaceuticals (IRWD) reported total liabilities & equity of $434.57M in Q1 2026.
- How has Ironwood Pharmaceuticals's total liabilities & equity changed year-over-year?
- Ironwood Pharmaceuticals's total liabilities & equity increased by 32.8% year-over-year, from $327.21M to $434.57M.
- What is the long-term trend for Ironwood Pharmaceuticals's total liabilities & equity?
- Over 5 years (2020 to 2025), Ironwood Pharmaceuticals's total liabilities & equity has grown at a -6.6% compound annual growth rate (CAGR), from $559.24M to $396.9M.
- What does total liabilities & equity mean?
- Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.